Answers are grounded in this paper and cite their sources.
Reveals autonomic adverse events in patients on immune checkpoint inhibitors, indicating a need for careful monitoring.
Immune checkpoint inhibitors (ICIs) are now standard of care for most advanced solid tumors. While effective, they are associated with immune-related adverse events (irAEs), including rare autonomic complications. We present a patient with metastatic lung adenocarcinoma receiving nivolumab and ipilimumab who developed reflex syncope with reproducible complete heart block (CHB) triggered by swallowing and food proximity. Barium esophagram revealed esophageal dysmotility, a small hiatal hernia, and distal esophageal narrowing. ICI therapy was held, and a dual-chamber pacemaker resolved the syncopal episodes. The overlap between structural esophageal pathology, possible ICI-associated autonomic dysregulation, and situational syncope complicates diagnosis and management. Clinicians should maintain vigilance for autonomic manifestations, especially new-onset bradyarrhythmias or syncope, in patients on immunotherapy.
No takes yet. Share an insight, caveat, or question.
Bouzon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: